pragma.vision Technology observatory

Verification register Bio, Health & Neuro

Living definition

What is Lipfendra (enlicitide)?

Drug Discovery & Development Bio, Health & Neuro

As of
2026-07-23
Revision
2026-07-26.1
Method
v1.3.0

Definition

The term, in context

AI-assisted draft · approved dataset

Lipfendra (enlicitide) is an orally administered PCSK9 inhibitor for lowering LDL cholesterol, reaching through a pill the target that established PCSK9 therapies address by injection.

Live readiness status

Status as of the current dateline

AI-assisted assembly · derived results

As of 2026-07-23, verified readiness is 78 (claimed 92, reported 88, gap 14) — Critical evidence strength; current signals suggest Track; not yet.

The readiness fact belongs to the canonical Readiness Verdict for Lipfendra (enlicitide).

Dataset approval

Human editorial release

pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)

Dataset
2026-07-26.1
Hash
sha256:a5b861157968f418e08e6a08da71c7cfd4c6b23c3955d9d77ad5bcf67b9e2482
Approved
2026-07-26

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.